Human translational studies investigating the neurocognitive effects of 5-HT4 receptor agonism
<p>Major depression is common, costly, and a global cause of significant morbidity. First-line antidepressant medication has a clinically problematic delay before therapeutic efficacy and is ineffective for a subset of those affected. In addition, many patients with depression, as well as othe...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2022
|
| Aiheet: |